Thursday, April 03, 2014

Top Novartis senior managers quit in Japan fraud scandal...

Swiss pharmaceutical giant Novartis is replacing the top executives at its Japanese unit over allegations the division hid serious potential side effects of leukaemia treatments from regulators.

The senior managers "resigned, they are out of the company", David Epstein, head of the firm's pharmaceutical division, said on Thursday.

"This kind of behaviour is unacceptable and a clear violation of our code of conduct," he told a press briefing in Tokyo.

"I'd like to once again apologize for Novartis' involvement in this issue."

The move comes after a panel of outside lawyers hired by the company said earlier Thursday that sales staff also hid their improper involvement in drug studies probing possible side effects of cancer treatments.

 The claims marked another blow for the drugmaker, less than two months after Japanese prosecutors raided its Tokyo office over claims Novartis exaggerated the benefits of a popular blood-pressure drug. Full story...

Related posts:
  1. Japanese raid Novartis offices in criminal probe...
  2. Japan to file criminal action against Novartis...
  3. Japan pursues Novartis unit over 'fake' drug data...
  4. Novartis eye care unit hit by China bribery claims...
  5. Japanese university to retract Novartis study for fabricated data...
  6. Novartis under fire over false Japanese drug data...
  7. Italy slaps Swiss pharma giants Novartis and Roche with huge fines...

No comments:

Post a Comment